Aptevo Therapeutics shares are trading lower after the company announced a $2.75 million offering.
Portfolio Pulse from Benzinga Newsdesk
Aptevo Therapeutics shares are trading lower following the announcement of a $2.75 million offering.
June 28, 2024 | 3:22 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Aptevo Therapeutics shares are trading lower after the company announced a $2.75 million offering.
The announcement of a $2.75 million offering typically dilutes existing shares, leading to a decrease in share price. This is reflected in the immediate trading lower of Aptevo Therapeutics shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100